Chiral protein type

The use of protein immobilised to the surface of a silica gel or to another support has been a very successful approach for the chiral separation of various pharmaceuticals. The AGP stationary phase has been shown to have the broadest enantiorecognition abilities while the BSA stationary phase is especially useful for aromatic compounds. " Table 9 shows some examples of separations that were obtained on the protein-type of CSPs. 

The usefulness of protein-type CSPs has already been shown in particular Chiral-AOP and Ultron ES-OVM (see Table 2) have a very broad range of enantioselectivity. It is not, however, possible to systematically predict the resolution on such CSPs, but the overall retention, selectivity and efficiency can be modified to a certain extent by altering several key variables ... 

Silica-base stationary phases have also been employed for enantiomeric separations in CEC [6,72-81]. In the initial work on chiral CEC, commercially available HPLC materials were utilized, including cyclodextrins [6,74,81] and protein-type selectors [73,75,80] such as human serum albumin [75] and ai-acid glycoprotein [73]. Fig. 4.9, for example, depicts the structure of a cyclodextrin-base stationary phase used in CEC and the separation of mephobarbital enantiomers by capillary LC and CEC in a capillary column packed with such a phase. The column operated in the CEC mode affords higher separation efficiency than in the capillary LC mode. Other enantiomeric selectors are also use in CEC, including the silica-linked or silica-coated macrocyclic antibiotics vancomycin [82,83] and teicoplanin [84], cyclodextrin-base polymer coated silicas [72,78], and weak anion-exchage type chiral phases [85]. Relatively high separation efficiency and excellent resolution for a variety of compounds have also been achieved using columns packed with naproxen-derived and Whelk-0 chiral stationary phases linked to 3 pm silica particles [79]. Fig. 4.10 shows the... 

Besides the conventional factors causing peak broadening in LC. another source for lower efficiency in LC with chiral stationary phases may be the existence of at least two different adsorption sites (the stereoselective and non-stereoselective ones) that may considerably differ in their adsorption kinetics (heterogeneous mass transfer kinetics) and thus cause peak broadening and tailing. These factors have been investigated and modelled by Fomstedt et al.. e.g. for protein type CSPs [75,91-9.3] and their contribution was determined for different analytes and different type of CSPs (bovine serum albumin, cellobiohydrolase 1, tris(4-methylbenzoyl) cellulose) [94j. In a recent study, these authors reported on the adsorption isotherms as well as selective and nonselective contributions of propranolol enantiomers on a cellobiohydrolase 1 CSP in dependence of the mobile phase pH [95[. 

Parallel to the n-donor-acceptor CSPs related to Pirkle s pioneering work for the understanding of chiral recognition phenomena and for gaining insight into SO-SA complexation principles on the molecular level, the protein type CSPs can claim a major credit for the rapid development of chiral technology in pharmaceutical and life sciences. 

One popular strategy to isolate and identify the binding domain of a protein type CSP is to compare the retention and enantioselectivity behaviour of CSPs prepared with whole proteins and with isolated protein domains. Such a study has been performed by Pinkerton et al. [204) with turkey ovomucoid. Columns made from whole-turkey ovomucoid displayed chiral activity toward many racemates, whereas the fused first and second domain resolved only a selected number of aromatic weak bases. The first and second domains independently expressed no appreciable chiral recognition activity. The third domain, however, exhibited enantioselective protein binding for fused-ring aromatic weak acids, and glycosylation of this domain did not affect chiral recognition. 

ENANTIOSEPARATION OF PHARMACEUTICALLY RELEVANT CHIRAL COMPOUNDS USING PROTEIN TYPE CSPs... 

In addition, due to the intermediate size of the chiral SO units, the loadability may not compete with CSPs based on low-molecular SOs however, it is much higher than for protein type CSPs [278]. 

Chiral Chromatography. Chiral chromatography is used for the analysis of enantiomers, most useful for separations of pharmaceuticals and biochemical compounds (see Biopolymers, analytical techniques). There are several types of chiral stationary phases those that use attractive interactions, metal ligands, inclusion complexes, and protein complexes. The separation of optical isomers has important ramifications, especially in biochemistry and pharmaceutical chemistry, where one form of a compound may be bioactive and the other inactive, inhibitory, or toxic. 

There is a wide variety of commercially available chiral stationary phases and mobile phase additives.32 34 Preparative scale separations have been performed on the gram scale.32 Many stationary phases are based on chiral polymers such as cellulose or methacrylate, proteins such as human serum albumin or acid glycoprotein, Pirkle-type phases (often based on amino acids), or cyclodextrins. A typical application of a Pirkle phase column was the use of a N-(3,5-dinitrobenzyl)-a-amino phosphonate to synthesize several functionalized chiral stationary phases to separate enantiomers of... 

Chiral separations result from the formation of transient diastereomeric complexes between stationary phases, analytes, and mobile phases. Therefore, a column is the heart of chiral chromatography as in other forms of chromatography. Most chiral stationary phases designed for normal phase HPLC are also suitable for packed column SFC with the exception of protein-based chiral stationary phases. It was estimated that over 200 chiral stationary phases are commercially available [72]. Typical chiral stationary phases used in SFC include Pirkle-type, polysaccharide-based, inclusion-type, and cross-linked polymer-based phases. 

Different classifications for the chiral CSPs have been described. They are based on the chemical structure of the chiral selectors and on the chiral recognition mechanism involved. In this chapter we will use a classification based mainly on the chemical structure of the selectors. The selectors are classified in three groups (i) CSPs with low-molecular-weight selectors, such as Pirkle type CSPs, ionic and ligand exchange CSPs, (ii) CSPs with macrocyclic selectors, such as CDs, crown-ethers and macrocyclic antibiotics, and (iii) CSPs with macromolecular selectors, such as polysaccharides, synthetic polymers, molecular imprinted polymers and proteins. These different types of CSPs, frequently used for the analysis of chiral pharmaceuticals, are discussed in more detail later. 

---